Pyrimidinones as casein kinase II (CK2) modulators

A compound according to Formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R6, R7 and Z are as defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ARLYN ARCALAS, JOERG BUSSENIUS, JEAN-CLAIRE LIMUN MANALO, CHARLES M. BLAZEY, WAI KI VICKY CHAN, NEEL KUMAR ANAND, PATRICK KEARNEY, PEIWEN ZHOU, TSZE H. TSANG, SERGEY EPSHTEYN, CSABA J. PETO, ABIGAIL R. KENNEDY, HONGWANG DU, MOHAMED ABDULKADER IBRAHIM, MOON HWAN KIM, AMY LEW TSUHAKO, KENNETH D. RICE
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A compound according to Formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R6, R7 and Z are as defined in the specification; pharmaceutical compositions thereof; and methods of use thereof.